| | |||||||
| Ebola | |||||||
| NEWS | |||||||
| Ebola Drug Remdesivir Shows Early Signs Of Hope In Treating COVID Patients A drug used to treat Ebola patients, Redesivir, is showing signs of hope against the COVID-19 virus in early trials, according to a press release from ...
| |||||||
| US study finds Ebola drug shows promise, but scientists urge caution The drug remdesivir appears to significantly speed patients' recovery from COVID-19, according to preliminary data from a large US ...
| |||||||
Coronavirus in Scotland LIVE: Nicola Sturgeon expects lockdown to be extended beyond May 7 Ebola drug shows 'very encouraging' results in Covid-19 battle. An antiviral drug previously used to treat ebola has shown "very encouraging results" at ...
| |||||||
| Zurik: Contact Tracing The man credited with organizing Liberia's response to Ebola says the key to coronavirus is contact tracing. April 29, 2020 at 4:45 PM CDT - Updated ...
| |||||||
| Africa's Covid-19 response is a glimpse of how things could be different As during the Ebola outbreak, the bucket, invented by Veronica Bekoe, a Ghanaian public health official, is appearing outside offices and malls, and in ...
| |||||||
| Compared With China, US Stay-At-Home Has Been 'Giant Garden Party,' Journalist Says He's covered AIDS, Ebola, malaria, swine and bird flu, SARS and other infectious diseases, and he's been talking to a wide range of experts about the ...
| |||||||
| Sealy & Smith gives UTMB in Galveston $3.35M for COVID-19 work "UTMB scientists were instrumental in leading the fight against Ebola and Zika," said John Kelso, chairman of The Sealy & Smith Foundation Board of ...
| |||||||
| US expert Fauci upbeat on virus drug Gilead Sciences says its drug remdesivir, initially developed for Ebola, could lead to positive outcomes for patients with the coronavirus. Deutsche ...
| |||||||
| See more results | Edit this alert | |||||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
Tidak ada komentar:
Posting Komentar